Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Abstract P2-20-03: Combination Therapy with an Anti-GD2 Antibody, Transforming Growth Factor Beta Imprinted Natural Killer Cells and Gemcitabine Improve Tumor Control and Survival in a Triple Negative Breast Cancer Model

Marcelo Pereira, Prashant Trikha, Sumithira Vasu, Zihai Li, Daniel Stover, Dean Lee, Margaret Gatti-Mays

Cancer Res (2023) 83 (5_Supplement): P2-20-03.

https://doi.org/10.1158/1538-7445.SABCS22-P2-20-03

Published: 01 March 2023

View article titled, Abstract P2-20-03: Combination Therapy with an Anti-GD2 Antibody, Transforming Growth Factor Beta Imprinted Natural Killer Cells and Gemcitabine Improve Tumor Control and Survival in a Triple Negative Breast Cancer Model

Journal Articles

Abstract 553: Ibrutinib, a BTK inhibitor, impairs the generation and function of myeloid derived suppressor cells

Andrew R. Stiff, Prashant Trikha, Robert Wesolowski, Kari Kendra, Sarvani Uppati, David Abood, Elizabeth McMichael, Megan Duggan, Amanda Campbell, Natarajan Muthusamy, Susheela Tridandapani, Michael Caliguiri, John C. Byrd, William E. Carson

Cancer Res (2016) 76 (14_Supplement): 553.

https://doi.org/10.1158/1538-7445.AM2016-553

Published: 15 July 2016

View article titled, Abstract 553: Ibrutinib, a BTK inhibitor, impairs the generation and function of myeloid derived suppressor cells

Journal Articles

Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib Treatment

Cancer Res (2016) 76 (8): 2125–2136.

https://doi.org/10.1158/0008-5472.CAN-15-1490

Published: 14 April 2016

View article titled, Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib Treatment

Journal Articles

Abstract 3656: MDSC-generated nitric oxide leads to an impairment of NK cell functions in metastatic melanoma patients

Prashant Trikha, Bethany Mundy-Bosse, Ian Landi, Elizabeth McMichael, Amanda Harper, Megan Duggan, Nancy Stasik, Kari Kendra, Thomas Olencki, William Carson

Cancer Res (2014) 74 (19_Supplement): 3656.

https://doi.org/10.1158/1538-7445.AM2014-3656

Published: 01 October 2014

View article titled, Abstract 3656: MDSC-generated nitric oxide leads to an impairment of NK cell functions in metastatic melanoma patients

Journal Articles

Abstract 388: mS100a7a15 enhances mammary tumor growth and metastasis by recruiting tumor associated macrophages

Mohd W. Nasser, Zahida Qamri, Yadwinder S. Deol, Janani Ravi, Catherine A. Powell, Prashant Trikha, Reto A. Schwendener, Konstantin Shilo, Ronald Wolf, Stuart H. Yuspa, Ramesh K. Ganju

Cancer Res (2012) 72 (8_Supplement): 388.

https://doi.org/10.1158/1538-7445.AM2012-388

Published: 15 April 2012

View article titled, Abstract 388: mS100a7a15 enhances mammary tumor growth and metastasis by recruiting tumor associated macrophages

Journal Articles

S100A7 Enhances Mammary Tumorigenesis through Upregulation of Inflammatory Pathways

Mohd W. Nasser, Zahida Qamri, Yadwinder S. Deol, Janani Ravi, Catherine A. Powell, Prashant Trikha, Reto A. Schwendener, Xue-Feng Bai, Konstantin Shilo, Xianghong Zou, Gustavo Leone, Ronald Wolf, Stuart H. Yuspa, Ramesh K. Ganju

Cancer Res (2012) 72 (3): 604–615.

https://doi.org/10.1158/0008-5472.CAN-11-0669

Published: 31 January 2012

View article titled, S100A7 Enhances Mammary Tumorigenesis through Upregulation of Inflammatory Pathways

Includes: Supplementary data

Journal Articles

Abstract 1349: Ablation of E2f3 in macrophages reduces the incidence of lung metastasis

Prashant Trikha, Clarissa Pena, Nidhi Sharma, Andreas Reyes, Gustavo Leone

Cancer Res (2010) 70 (8_Supplement): 1349.

https://doi.org/10.1158/1538-7445.AM10-1349

Published: 15 April 2010

View article titled, Abstract 1349: Ablation of <em>E2f3</em> in macrophages reduces the incidence of lung metastasis

NARROW

Abstract P2-20-03: Combination Therapy with an Anti-GD2 Antibody, Transforming Growth Factor Beta Imprinted Natural Killer Cells and Gemcitabine Improve Tumor Control and Survival in a Triple Negative Breast Cancer Model

Abstract 553: Ibrutinib, a BTK inhibitor, impairs the generation and function of myeloid derived suppressor cells

Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib Treatment

Abstract 3656: MDSC-generated nitric oxide leads to an impairment of NK cell functions in metastatic melanoma patients

Abstract 388: mS100a7a15 enhances mammary tumor growth and metastasis by recruiting tumor associated macrophages

S100A7 Enhances Mammary Tumorigenesis through Upregulation of Inflammatory Pathways

Abstract 1349: Ablation of E2f3 in macrophages reduces the incidence of lung metastasis

Email alerts

AACR Journals

Abstract P2-20-03: Combination Therapy with an Anti-GD2 Antibody, Transforming Growth Factor Beta Imprinted Natural Killer Cells and Gemcitabine Improve Tumor Control and Survival in a Triple Negative Breast Cancer Model

Abstract 553: Ibrutinib, a BTK inhibitor, impairs the generation and function of myeloid derived suppressor cells

Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib Treatment

Abstract 3656: MDSC-generated nitric oxide leads to an impairment of NK cell functions in metastatic melanoma patients

Abstract 388: mS100a7a15 enhances mammary tumor growth and metastasis by recruiting tumor associated macrophages

S100A7 Enhances Mammary Tumorigenesis through Upregulation of Inflammatory Pathways

Abstract 1349: Ablation of E2f3 in macrophages reduces the incidence of lung metastasis

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only